These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 16919261)

  • 1. Azelnidipine, a new calcium channel blocker, inhibits endothelial inflammatory response by reducing intracellular levels of reactive oxygen species.
    Naito Y; Shimozawa M; Manabe H; Nakabe N; Katada K; Kokura S; Yoshida N; Ichikawa H; Kon T; Yoshikawa T
    Eur J Pharmacol; 2006 Sep; 546(1-3):11-8. PubMed ID: 16919261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 7-Ketocholesterol enhances the expression of adhesion molecules on human aortic endothelial cells by increasing the production of reactive oxygen species.
    Shimozawa M; Naito Y; Manabe H; Uchiyama K; Kuroda M; Katada K; Yoshida N; Yoshikawa T
    Redox Rep; 2004; 9(6):370-5. PubMed ID: 15720835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viscolin reduces VCAM-1 expression in TNF-α-treated endothelial cells via the JNK/NF-κB and ROS pathway.
    Liang CJ; Wang SH; Chen YH; Chang SS; Hwang TL; Leu YL; Tseng YC; Li CY; Chen YL
    Free Radic Biol Med; 2011 Oct; 51(7):1337-46. PubMed ID: 21767632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azelnidipine, a new long-acting calcium-channel blocker, inhibits tumour necrosis factor-alpha-induced monocyte chemoattractant protein-1 expression in endothelial cells.
    Matsui T; Yamagishi S; Nakamura K; Inoue H
    J Int Med Res; 2006; 34(6):671-5. PubMed ID: 17295000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bay w 9798, a dihydropyridine structurally related to nifedipine with no calcium channel-blocking properties, inhibits tumour necrosis factor-alpha-induced vascular cell adhesion molecule-1 expression in endothelial cells by suppressing reactive oxygen species generation.
    Matsui T; Yamagishi S; Nakamura K; Inoue H
    J Int Med Res; 2007; 35(6):886-91. PubMed ID: 18084847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibitory effect of alacepril, an angiotensin-converting enzyme inhibitor, on endothelial inflammatory response induced by oxysterol and TNF-alpha.
    Shimozawa M; Naito Y; Manabe H; Uchiyama K; Katada K; Kuroda M; Nakabe N; Yoshida N; Yoshikawa T
    Redox Rep; 2004; 9(6):354-9. PubMed ID: 15720832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isorhamnetin prevent endothelial cell injuries from oxidized LDL via activation of p38MAPK.
    Bao M; Lou Y
    Eur J Pharmacol; 2006 Oct; 547(1-3):22-30. PubMed ID: 16963021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azelnidipine, a newly developed long-acting calcium antagonist, inhibits tumor necrosis factor-alpha-induced interleukin-8 expression in endothelial cells through its anti-oxidative properties.
    Yamagishi S; Inagaki Y; Nakamura K; Imaizumi T
    J Cardiovasc Pharmacol; 2004 May; 43(5):724-30. PubMed ID: 15071361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SDF-1-induced adhesion of monocytes to vascular endothelium is modulated by azelnidipine via protein kinase C inhibition.
    Takahashi K; Shimokado K; Yoshida M
    Eur J Pharmacol; 2006 Dec; 552(1-3):162-9. PubMed ID: 17067573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnolol attenuates VCAM-1 expression in vitro in TNF-alpha-treated human aortic endothelial cells and in vivo in the aorta of cholesterol-fed rabbits.
    Chen YH; Lin SJ; Chen JW; Ku HH; Chen YL
    Br J Pharmacol; 2002 Jan; 135(1):37-47. PubMed ID: 11786478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azelnidipine, a dihydropyridine-based calcium antagonist, inhibits angiotensin II-induced oxidative stress generation and downregulation of pigment epithelium-derived factor mRNA levels in microvascular endothelial cells.
    Matsui T; Yamagishi S; Nakamura K; Kikuchi S; Inoue H
    Drugs Exp Clin Res; 2005; 31(5-6):215-9. PubMed ID: 16425978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azelnidipine is a calcium blocker that attenuates liver fibrosis and may increase antioxidant defence.
    Ohyama T; Sato K; Kishimoto K; Yamazaki Y; Horiguchi N; Ichikawa T; Kakizaki S; Takagi H; Izumi T; Mori M
    Br J Pharmacol; 2012 Feb; 165(4b):1173-87. PubMed ID: 21790536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Inflammatory effect of Buddleja officinalis on vascular inflammation in human umbilical vein endothelial cells.
    Lee YJ; Moon MK; Hwang SM; Yoon JJ; Lee SM; Seo KS; Kim JS; Kang DG; Lee HS
    Am J Chin Med; 2010; 38(3):585-98. PubMed ID: 20503474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clematichinenoside inhibits VCAM-1 and ICAM-1 expression in TNF-α-treated endothelial cells via NADPH oxidase-dependent IκB kinase/NF-κB pathway.
    Yan S; Zhang X; Zheng H; Hu D; Zhang Y; Guan Q; Liu L; Ding Q; Li Y
    Free Radic Biol Med; 2015 Jan; 78():190-201. PubMed ID: 25463279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of benidipine, a dihydropyridine-Ca2+ channel blocker, on expression of cytokine-induced adhesion molecules and chemoattractants in human aortic endothelial cells.
    Matsubara M; Hasegawa K
    Eur J Pharmacol; 2004 Sep; 498(1-3):303-14. PubMed ID: 15364009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolic acid attenuates the tumour necrosis factor-α-mediated proinflammatory response in endothelial cells by blocking the MAPK/NF-κB and ROS pathways.
    Olejarz W; Bryk D; Zapolska-Downar D; Małecki M; Stachurska A; Sitkiewicz D
    Eur J Clin Invest; 2014 Jan; 44(1):54-64. PubMed ID: 24134657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chloroform extract of aged black garlic attenuates TNF-α-induced ROS generation, VCAM-1 expression, NF-κB activation and adhesiveness for monocytes in human umbilical vein endothelial cells.
    Lee EN; Choi YW; Kim HK; Park JK; Kim HJ; Kim MJ; Lee HW; Kim KH; Bae SS; Kim BS; Yoon S
    Phytother Res; 2011 Jan; 25(1):92-100. PubMed ID: 20623600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique atheroprotective property of azelnidipine, a dihydropyridine-based calcium antagonist.
    Nakamura K; Yamagishi S; Inoue H
    Med Hypotheses; 2005; 65(1):155-7. PubMed ID: 15893134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidative effects of azelnidipine on mesangial cell proliferation induced by highly concentrated insulin.
    Manabe S; Okura T; Fukuoka T; Higaki J
    Eur J Pharmacol; 2007 Jul; 567(3):252-7. PubMed ID: 17544393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azelnidipine suppresses the progression of aortic aneurysm in wild mice model through anti-inflammatory effects.
    Kurobe H; Matsuoka Y; Hirata Y; Sugasawa N; Maxfield MW; Sata M; Kitagawa T
    J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1501-8. PubMed ID: 23535154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.